Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Stuthi Perimbeti is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Angelica herbal supplement AGN-Cogni.Q acute dose safety and pharmacokinetics (PK) dose-response in prostate cancer patients.
Joshi, M., Fan, T., Schell, T. D., Liu, X., Perimbeti, S., Wheelden, M., Sun, D., Desai, D., Shank, D., Strong, A. L., Raman, J. D., Liao, J., Jiang, C. & Lu, J., Mar 2026, In: Journal of Clinical Oncology. 44, p. 372 1 p.Research output: Contribution to journal › Article › peer-review
-
Computational pathology features of immune architecture predict clinically relevant outcomes in small-cell lung cancer (SCLC)
Barrera, C., Jain, P., Corredor, G., Dam, T., Maurya, H., Pathak, T., Beshai, B., Perimbeti, S., Jagirdar, J., Higgins, K., Dowlati, A. & Madabhushi, A., Dec 2026, In: npj Precision Oncology. 10, 1, 119.Research output: Contribution to journal › Article › peer-review
Open Access -
Evaluation of the safety and efficacy of daily oral Angelica gigas Nakai (AGN)-INM176 in prostate cancer patients with rising plasma PSA (phase I/II trial).
Joshi, M., Schell, T. D., Liu, X., Perimbeti, S., Wheelden, M., Polimera, H. V., Sun, D., Shank, D., Strong, A. L., Raman, J. D., Liao, J., Jiang, C. & Lu, J., Mar 2026, In: Journal of Clinical Oncology. 44, p. TPS413-TPS413Research output: Contribution to journal › Article › peer-review
-
Angelica gigas Nakai (Korean Dang-gui) Root Alcoholic Extracts in Health Promotion and Disease Therapy – active Phytochemicals and In Vivo Molecular Targets
Lü, J., Jiang, C., Drabick, J. J., Joshi, M. & Perimbeti, S., Jan 2025, In: Pharmaceutical Research. 42, 1, p. 25-47 23 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Link opens in a new tab Scopus citations -
Phase Ib study of enzalutamide with venetoclax in patients with metastatic castration-resistant prostate cancer
Perimbeti, S., Jamroze, A., Gopalakrishnan, D., Jain, R., Jiang, C., Holleran, J. L., Parise, R. A., Bies, R., Quinn, D., Attwood, K., Liu, X., Green, K., Kirk, J. S., Beumer, J. H., Tang, D. G. & Chatta, G., Dec 2025, In: Cancer Chemotherapy and Pharmacology. 95, 1, 115.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Scopus citations